3rd Supply Chain and Logistics for Cell Therapies Summit


    Keen to unite with your #celltherapy supply chain community and gain actionable insights for streamlining logistics, implementing digital platforms and optimizing patient operations to establish a reliable global delivery of cell therapies?

    Then look no further! The 3rd Supply Chain & Logistics for Cell Therapies Summit is back and taking place in-person for the first time this 25-27 April 2022!

    View the full 3-day agenda here: https://ter.li/5pzucl

    2022 Agenda Overview:

    With exclusive presentations and interactive talks on key industry challenges, gain valuable takeaways from leaders in the field from GlaxoSmithKline, Legend Biotech, Iovance, Gamida Cell, and more. Discuss standardization, review digital system implementation, prepare for upscaling and optimize cryopreservation in person with like-minded supply chain professionals all to maximize efficiency and create a patient-centric end-to-end system.

    Download the full event guide to learn more about our speakers, agenda topics, and face-to-face networking opportunities. https://ter.li/5pzucl

    Detailed Event Name: 3rd Supply Chain & Logistics for Cell Therapies Summit
    Event Venue:Crowne Plaza Woburn,15 Middlesex Canal Park Rd, Woburn,MA 01801
    Event Date: April 25-27
    Event website link:https://ter.li/2fgm4l
    Complete Event Organizer Name: Hanson Wade
    Communication number (with country & area code):
    Email ID: info@hansonwade.com

    Organiser: Hanson Wade


    Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

    Hanson Wade conferences span high growth fields from pioneering life science, to technology-augmented construction, to radical change in HR. We run events globally, across a huge variety of topics. Our conferences are built where rapid change leads to greater opportunity for those that are most informed.